Factors affecting portal vein clot reopening in cirrhosis
Part of Digestive system clinical trials.
This study looks at factors that help open up blood clots in the main vein to the liver (portal vein) in people with cirrhosis and varices. It might help guide treatment to improve blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis and a doctor has seen swollen veins in your esophagus or stomach (varices) during an endoscopy.
- You have a blood clot in the portal vein (the main vein to your liver) confirmed by a CT scan.
- You do not have liver cancer or any other cancer outside the liver.
- You have not had a liver transplant or a TIPS procedure (a stent in the liver).
- You are not taking blood thinners? (Information about anticoagulation therapy is needed.)
- You do not have a condition called cavernous transformation of the portal vein (a network of small veins that form around a blocked portal vein).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is following people with cirrhosis to see how often they get a blood clot in the liver's main vein (portal vein) and whether using blood thinners helps. If you have cirrhosis, joining this study could help doctors learn better ways to prevent and treat these clots.
This study tests whether placing a TIPS (a small tube in the liver to improve blood flow) early after a variceal bleed helps people with cirrhosis and a partial portal vein clot. It may reduce the risk of re-bleeding and improve outcomes.
This study looks at how blood clots in the portal vein (the main vein to your liver) affect recovery and outcomes after a liver transplant. If you've had a liver transplant, your data may help doctors understand this better.
This study tests a TIPS stent graft (a tiny mesh tube placed in the liver to relieve pressure) for people with cirrhosis and complications like bleeding or fluid buildup. It aims to see how well it works and if it's safe.
This study tests a new version of a device (VIATORR TIPS) that helps lower high blood pressure in the liver for people with cirrhosis. The device is placed to create a small channel that reroutes blood flow and reduces pressure.
This trial tests whether a pill (dabigatran) or a daily injection (enoxaparin) is better at preventing new blood clots in the liver vein for people with cirrhosis. Both are blood thinners, and the study wants to see which one is safer and more effective.
Hear when a new Portal Vein Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.